Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study

BACKGROUND: Early prediction of treatment response is crucial for the optimal treatment of advanced breast cancer. We aimed to explore whether monitoring early changes in plasma human epidermal growth factor receptor 2 (HER2) levels using digital PCR (dPCR) could predict the treatment response in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yi‐Kun, Si, Yi‐Ran, Ju, Jie, Jia, Zhu‐Qing, Hu, Nan‐Lin, Dong, Hao, Wang, Xue, Yue, Jian, Jiang, Pei‐Di, Li, Zhao‐Liang, Zhang, Yun‐Yun, Wang, Yan, Xu, Bing‐He, Yuan, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028130/
https://www.ncbi.nlm.nih.gov/pubmed/36281495
http://dx.doi.org/10.1002/cam4.5352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028130/
https://www.ncbi.nlm.nih.gov/pubmed/36281495
http://dx.doi.org/10.1002/cam4.5352

Ejemplares similares